Journal of Obstetrics, Gynecology and Cancer Research

Published by: Kowsar

Menstrual Adjustment Administering Hormonal Agents: A Survey of Iranian Pilgrim Women During Long-Term Travel

Fakhrolmolouk Yassaee 1 , * , Reza Shekarriz-Foumani 2 and Shima Sadeghi 3
Authors Information
1 MD, Taleghani Hospital, Genomic Research Center, Obstetrics and Gynecology Department, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 MD, MPH, Community Medicine Department, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Master of Control Engineering, Department of Electrical, Biomedical and Mechatronics Engineering, Qazvin Branch, Islamic Azad University, Qazvin, IR Iran
Article information
  • Journal of Obstetrics, Gynecology and Cancer Research: November 2017, 2 (4); e60985
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: August 28, 2017
  • Accepted: October 31, 2017
  • DOI: 10.5812/jogcr.60985

To Cite: Yassaee F, Shekarriz-Foumani R, Sadeghi S. Menstrual Adjustment Administering Hormonal Agents: A Survey of Iranian Pilgrim Women During Long-Term Travel, J Obstet Gynecol Cancer Res. 2017 ;2(4):e60985. doi: 10.5812/jogcr.60985.

Copyright: Copyright © 2017, Journal of Obstetrics, Gynecology and Cancer Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States, 1982-1995. Fam Plann Perspect. 1998;30(1):4-10. 46. [PubMed: 9494809].
  • 2. Rosenberg MJ, Burnhill MS, Waugh MS, Grimes DA, Hillard PJ. Compliance and oral contraceptives: a review. Contraception. 1995;52(3):137-41. [PubMed: 7587184].
  • 3. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995;51(5):283-8. [PubMed: 7628201].
  • 4. Christopher LA, Miller L. Women in war: operational issues of menstruation and unintended pregnancy. Mil Med. 2007;172(1):9-16. [PubMed: 17274258].
  • 5. Hitchcock CL, Prior JC. Evidence about extending the duration of oral contraceptive use to suppress menstruation. Womens Health Issues. 2004;14(6):201-11. doi: 10.1016/j.whi.2004.08.005. [PubMed: 15589770].
  • 6. Powell-Dunford N, Cuda AS, Moore JL, Crago MS, Deuster PA. Menstrual suppression using oral contraceptives: survey of deployed female aviation personnel. Aviat Space Environ Med. 2009;80(11):971-5. [PubMed: 19911522].
  • 7. Archer DF. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception. 2006;74(5):359-66. doi: 10.1016/j.contraception.2006.06.003. [PubMed: 17046376].
  • 8. Benagiano G, Carrara S, Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Prefer Adherence. 2009;3:131-43. [PubMed: 19936155].
  • 9. De Voogd WS. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinylestradiol. Contraception. 1991;44(2):107-12. doi: 10.1016/0010-7824(91)90111-r.
  • 10. Edelman AB, Gallo MF, Jensen JT, Nichols MD, Schulz KF, Grimes DA. Continuous or extended cycle vs, cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005;(3):4695. doi: 10.1002/14651858.CD004695.pub2. [PubMed: 16034942].
  • 11. Kaunitz AM. Menstruation: choosing whether...and when. Contraception. 2000;62(6):277-84. [PubMed: 11239613].
  • 12. Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003;67(1):9-13. [PubMed: 12521651].
  • 13. Lin K, Barnhart K. The clinical rationale for menses-free contraception. J Womens Health (Larchmt). 2007;16(8):1171-80. doi: 10.1089/jwh.2007.0332. [PubMed: 17937570].
  • 14. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004;64(21):2447-62. [PubMed: 15482002].
  • 15. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68(2):89-96. [PubMed: 12954519].
  • 16. Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007;75(6):444-9. doi: 10.1016/j.contraception.2007.01.014. [PubMed: 17519150].
  • 17. Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand. 2013;92(2):125-36. doi: 10.1111/aogs.12036. [PubMed: 23083413].
  • 18. Jacobson JC, Likis FE, Murphy PA. Extended and continuous combined contraceptive regimens for menstrual suppression. J Midwifery Womens Health. 2012;57(6):585-92. doi: 10.1111/j.1542-2011.2012.00250.x. [PubMed: 23217068].
  • 19. Lambert J, Newton W. Continuous use of oral contraceptives reduces bleeding. J Fam Pract. 2003;52(8):601-2. [PubMed: 12899813].
  • 20. Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br Med J. 1977;2(6085):487-90. [PubMed: 890363].
  • 21. Machado RB, de Melo NR, Maia HJ. Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study. Contraception. 2010;81(3):215-22. doi: 10.1016/j.contraception.2009.10.010. [PubMed: 20159177].
  • 22. Mendoza N, Lobo P, Lertxundi R, Correa M, Gonzalez E, Salamanca A, et al. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies. Eur J Contracept Reprod Health Care. 2014;19(5):321-39. doi: 10.3109/13625187.2014.927423. [PubMed: 24971489].
  • 23. Portman DJ, Reape KZ, Hait H, Howard BK. Reduction in dysmenorrhea severity in women using a 91 day extended regimen oral contraceptive compared to a 28 day regimen oral contraceptive for the treatment of cyclic pelvic pain. Fertil Steril. 2011;96(3):110-1. doi: 10.1016/j.fertnstert.2011.07.433.
  • 24. Seidman DS, Yeshaya A, Ber A, Amodai I, Feinstein I, Finkel I, et al. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone. Isr Med Assoc J. 2010;12(7):400-5. [PubMed: 20862819].
  • 25. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol. 2002;186(6):1142-9. [PubMed: 12066088].
  • 26. This P. [Reducing the frequency of menses: extended contraception, a review]. Gynecol Obstet Fertil. 2013;41(6):381-7. doi: 10.1016/j.gyobfe.2013.05.003. [PubMed: 23769012].
  • 27. Wiegratz I, Stahlberg S, Manthey T, Sanger N, Mittmann K, Lange E, et al. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy. Contraception. 2011;84(2):133-43. doi: 10.1016/j.contraception.2011.01.002. [PubMed: 21757054].
  • 28. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol. 2003;101(4):653-61. [PubMed: 12681866].
  • 29. Likis FE. Contraceptive applications of estrogen. J Midwifery Womens Health. 2002;47(3):139-56. [PubMed: 12071380].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader